Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329 (13 November), doi:10.1136/bmj.329.7475.0
A primary care led genetic screening programme for thalassaemia in Iran has proved feasible, acceptable, and effective. Samavat and Modell (p 1134) describe the development of Iran's national programme, which has resulted in a 70% reduction in expected births of affected infants. It provides a model for other countries, including developed countries, seeking to implement comprehensive, equitable, genetic screening programmes for haemoglobin disorders (p 1115).
|
|
Credit: ATTA KENARE/AFP/GETTY
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
What can you learn from this BMJ paper? Read Leanne Tite's Paper+